European Journal of Health Economics

Papers
(The H4-Index of European Journal of Health Economics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19693
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines144
Historical evidence for economic effects of COVID-19134
Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues85
COVID-19 and income inequality in OECD countries84
Cost and effects of integrated care: a systematic literature review and meta-analysis76
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe49
Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy41
The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes39
An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values36
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies36
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life34
The economic burden of obesity in Italy: a cost-of-illness study33
More room for telemedicine after COVID-19: lessons for primary care?32
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies31
COVID-19 and the role of inequality in French regional departments30
Healthcare expenditure and carbon footprint in the USA: evidence from hidden cointegration approach27
How expensive are post-traumatic stress disorders? Estimating incremental health care and economic costs on anonymised claims data26
EQ-5D-5L Bulgarian population norms25
Health effects from heat waves in France: an economic evaluation24
The “red herring” after 20 years: ageing and health care expenditures23
Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–201522
Modelling Covid-19 under uncertainty: what can we expect?22
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states22
The remarkably frequent use of EQ-5D in non-economic research22
0.0487380027771